AlphaFold predicted structure
SLC22A12 · Q96S37

Mean pLDDT
86.6/ 100
Confident
553 residues
Confidence breakdown
- Very high(≥ 90)54%
- Confident(70–90)37%
- Low(50–70)6%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 22 member 12
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Nephrocalcinosis or nephrolithiasis
BIALLELIC, autosomal or pseudoautosomalRenal tubulopathies
BIALLELIC, autosomal or pseudoautosomalAcute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BIALLELIC, autosomal or pseudoautosomalgout
hyperuricemia
hereditary renal hypouricemia
hypouricemia, renal
obesity disorder
acquired metabolic disease
overnutrition
Hypertension
obstructive sleep apnea syndrome
placenta praevia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Solute carrier family 22 member 12
Electroneutral antiporter that translocates urate across the apical membrane of proximal tubular cells in exchange for monovalent organic or inorganic anions (PubMed:12024214, PubMed:22194875, PubMed:35144162, PubMed:35462902). Involved in renal reabsorption of urate and helps maintaining blood levels of uric acid (PubMed:12024214, PubMed:22194875). Mediates urate uptake by an exchange with organic anions such as (S)-lactate and nicotinate, and inorganic anion Cl(-) (PubMed:12024214). Other inorganic anions such as Br(-), I(-) and NO3(-) may also act as counteranions that exchange for urate (PubMed:12024214). Also mediates orotate tubular uptake coupled with nicotinate efflux and to a lesser extent with lactate efflux, therefore displaying a potential role in orotate renal reabsorption (PubMed:21350910). Orotate transport is Cl(-)-dependent (PubMed:21350910)
Curated MONDO disease pages that list SLC22A12 among their top associated genes.
SLC22A12 · Q96S37

Mean pLDDT
86.6/ 100
Confident
553 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0